A phase I clinical trial of ruxolitinib in combination with nilotinib in chronic myeloid leukemia patients with molecular evidence of disease
Autor: | Sweet, Kendra, Hazlehurst, Lori, Sahakian, Eva, Powers, John, Nodzon, Lisa, Kayali, Fadi, Hyland, Kelly, Nelson, Ashley, Pinilla-Ibarz, Javier |
---|---|
Zdroj: | In Leukemia Research November 2018 74:89-96 |
Databáze: | ScienceDirect |
Externí odkaz: |